A 52-year-old woman on risperidone 4 mg daily for 8 years presents with persistent involuntary lip smacking, tongue protrusion, and choreiform hand movements. Which finding would best distinguish her condition from neuroleptic malignant syndrome?

Explanation

## Tardive Dyskinesia vs. Neuroleptic Malignant Syndrome ### Clinical Context The patient's 8-year antipsychotic exposure, orofacial dyskinesias, and choreiform movements point to **tardive dyskinesia (TD)**. The question asks what distinguishes TD from **neuroleptic malignant syndrome (NMS)** — a life-threatening emergency. ### Comparative Table | Feature | Tardive Dyskinesia | Neuroleptic Malignant Syndrome | |---------|-------------------|-------------------------------| | **Onset** | Months to years of continuous use | Hours to days after drug start/↑ dose | | **Presentation** | Involuntary choreiform, orofacial movements | Fever, rigidity, altered mental status, autonomic instability | | **Consciousness** | Alert, oriented, normal cognition | Altered consciousness, confusion, delirium | | **Temperature** | Normal | High fever (often >38.5°C) | | **Autonomic signs** | Absent | Tachycardia, hypertension, diaphoresis, labile BP | | **CK level** | Normal or mildly elevated | Markedly elevated (often >1000 IU/L) | | **Mortality** | None (morbidity from aspiration) | 10–20% if untreated | | **Reversibility** | Often irreversible | Reversible with prompt treatment | ### Why Option 2 (Gradual Onset + Normal Consciousness) is Correct **Key Point:** Tardive dyskinesia has a **gradual, insidious onset over months to years** and the patient remains **fully conscious and cognitively intact**. Neuroleptic malignant syndrome, by contrast, is an **acute medical emergency** with **altered mental status, fever, and autonomic crisis**. **High-Yield:** The combination of **long latency (8 years)** and **preserved consciousness with normal mental status** is pathognomonic for TD and rules out NMS, which presents acutely with delirium and systemic toxicity. ### Pathophysiology **Clinical Pearl:** - **TD:** Chronic dopamine blockade → dopamine receptor supersensitivity in basal ganglia → involuntary movements. No systemic inflammation or metabolic derangement. - **NMS:** Acute dopamine blockade in hypothalamus and brainstem → loss of thermoregulation, rigidity, and sympathetic hyperactivity. Involves rhabdomyolysis, myoglobinuria, and multi-organ dysfunction. ### Management Implications **TD Management:** - Reduce or discontinue antipsychotic if possible. - Consider tetrabenazine or valbenazine (VMAT2 inhibitors). - Switch to second-generation agent with lower TD risk. **NMS Management (Emergency):** - Immediate discontinuation of antipsychotic. - Supportive care: aggressive cooling, IV hydration. - Dantrolene or bromocriptine for severe cases. - ICU monitoring. [cite:Harrison 21e Ch 387; Stahl's Essential Psychopharmacology 6e Ch 11]